---
figid: PMC5732752__oncotarget-08-103581-g009
figlink: /pmc/articles/PMC5732752/figure/F9/
number: Figure 9
caption: (A) Schematic showing the KGFR signalling pathway and target of the pharmacological
  inhibitor. (B) Control (vehicle only) keratinocytes were differentiated in high
  calcium media and lysed after 48 hours. Parallel cultures of E5KO keratinocytes
  were treated with 30 nM of a KGFR kinase inhibitor (PD173074). Lysates were analysed
  for the phosphorylated forms of FRS2α, AKT, GSK3α/β, cytokeratin 1 (K1) and cyclin
  B1 by immunoblot.
pmcid: PMC5732752
papertitle: Human papillomavirus type 18 E5 oncogene supports cell cycle progression
  and impairs epithelial differentiation by modulating growth factor receptor signalling
  during the virus life cycle.
reftext: Christopher W. Wasson, et al. Oncotarget. 2017 Nov 28;8(61):103581-103600.
pmc_ranked_result_index: '15622'
pathway_score: 0.6156856
filename: oncotarget-08-103581-g009.jpg
figtitle: Human papillomavirus type 18 E5 oncogene supports cell cycle progression
  and impairs epithelial differentiation by modulating growth factor receptor signalling
  during the virus life cycle
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5732752__oncotarget-08-103581-g009.html
  '@type': Dataset
  description: (A) Schematic showing the KGFR signalling pathway and target of the
    pharmacological inhibitor. (B) Control (vehicle only) keratinocytes were differentiated
    in high calcium media and lysed after 48 hours. Parallel cultures of E5KO keratinocytes
    were treated with 30 nM of a KGFR kinase inhibitor (PD173074). Lysates were analysed
    for the phosphorylated forms of FRS2α, AKT, GSK3α/β, cytokeratin 1 (K1) and cyclin
    B1 by immunoblot.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD
  - PIK3CA
  - PIK3R4
  - FGFR2
  - PIK3CB
  - PIK3R5
  - AKT3
  - PIK3CG
  - PIK3R3
  - PIK3R6
  - GSK3B
  - FRS2
  - AKT1
  - GAPDH
  - AKT2
  - PD173074
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: KGFR
  symbol: KGFR
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: FRS2¤
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals:
- word: PD173074
  source: MESH
  identifier: C115711
diseases: []
---
